German Crowdfunding Platform Aescuvest Combines Institutional & Private Investors to Fund Health & Medical Startups

German Investment crowdfunding platform Aescuvest has recently listed an offer to invest in Rodos Biotarget GmbH. The company has reportedly developed a platform technology under the name TargoSphere, which allows the targeted transport of active substances with “nanotransporters”.  These nanotransporters. Rodos Biotarget is emblematic of the type of offering listed on the health and medical targeted crowdfunding platform. Rodos Biotarget is seeking a minimum funding of €100,000. Investors will receive a percentage of sales during a 5 year term with the principle of the initial investment repaid at the end of the term. This is the second crowdfunding round for Rodos Biotarget. The first crowdfunding offer was listed on Seedmatch in 2016.

Rodos Biotarget is pursueing two objectives: first, private investors should be given the opportunity to invest in early stage health care companies. Secondly, the company wants to tap into cooperation partners, customers and private equity through the crowdfunding campaign. The additional of the medical entrepreneur Otto H. Gies as an investor has aided this goal. Otto H. Gies created the 3B Scientific group that operated in over one hundred countries. He recently sold it to a US private equity company.  Gies believes in the Rodos Biotarget mission.

“The new nanomedicine developments of the Rodos Biotarget, in particular against diabetes and a number of liver diseases, is very convincing,” commented Dr. Marcus Furch, Managing Director of Rodos Biotarget. “We have been able to convince Mr. Gies, a highly experienced entrepreneur with a valuable international network of contacts.”

The financing round is also supported by the High-Tech Gründerfonds and the Hannoverian InvestImpuls funds.

Aescuvest is the first European Crowdinvesting platform specializing in the growing healthcare market including Medtech, Biotech, and digital health. Aescuvest allows both private and institutional investors the opportunity to invest in this industry. Aescuvest has a network of over 9,000 registered users as well as a group of more than 220,000 industry experts.e

 


Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Nov 7, 2026 vs Jan 1, 2025 - Nov 7, 2025

Share this graph
Number of Filings134Prior 129 +3.9%
Target Raise, Total$3.45BPrior $3.59B -3.8%
This YTDYear priorChange
Filings 134 129 +3.9%
Target raise $3.45B $3.59B -3.8%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend